IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus

被引:24
作者
Díaz-Alderete, A [1 ]
Crispin, JC [1 ]
Vargas-Rojas, MI [1 ]
Alcocer-Varela, J [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico
关键词
autoimmunity; CD154; IL-10; lupus; SLE;
D O I
10.1016/j.jaut.2004.10.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunological hallmark of SLE is B cell hyperactivity. CD154 (CD40-L) is normally expressed in activated T cells, and plays an important role in T-B interactions. Its expression is increased in SLE T cells. Additionally, its expression on B cells leads to the development of SLE-like disease in a transgenic model. IL-10 is a key cytokine in the disturbed SLE immune system. The aim of this work was to explore the relation between IL-10 and CD154 expression in SLE B cells. We studied 11 SLE patients and 10 healthy volunteers. Mononuclear cells were isolated from peripheral blood and cultured in the presence or absence of Cowan I Strain Staphylococcus (CSS). Surface CD154 and intracytoplasmic IL-10 expression were quantified with flow cytometry. In basal conditions, CD154 expression was not different in patients and controls. B cell stimulation did not cause a significant increase in CD154 expression in control B cells. However, its expression increased 2 times in B cells obtained from SLE patients. IL-10 expression was confined to CD154(+) cells. Our results show that IL-10 production is intimately linked to CD154 expression in B cells, and that the IL-10(+) CD154(+) B cell subset increases abnormally when SLE-derived cells are stimulated with CSS. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 383
页数:5
相关论文
共 23 条
[1]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[2]  
BARATHA SD, 1998, J AUTOIMMUN, V11, P471
[3]  
Blossom S, 1997, J IMMUNOL, V159, P4580
[4]  
CROW MK, 2003, RHEUMATOLOGY, P1347
[5]   Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production [J].
DesaiMehta, A ;
Lu, LJ ;
RamseyGoldman, R ;
Datta, SK .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (09) :2063-2073
[6]   Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM [J].
Ferrari, S ;
Giliani, S ;
Insalaco, A ;
Al-Ghonaium, A ;
Soresina, AR ;
Loubser, M ;
Avanzini, MA ;
Marconi, M ;
Badolato, R ;
Ugazio, AG ;
Levy, Y ;
Catalan, N ;
Durandy, A ;
Tbakhi, A ;
Notarangelo, LD ;
Plebani, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12614-12619
[7]   GP39-CD40 INTERACTIONS ARE ESSENTIAL FOR GERMINAL CENTER FORMATION AND THE DEVELOPMENT OF B-CELL MEMORY [J].
FOY, TM ;
LAMAN, JD ;
LEDBETTER, JA ;
ARUFFO, A ;
CLAASSEN, E ;
NOELLE, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :157-163
[8]   A SOLUBLE FORM OF TRAP (CD40 LIGAND) IS RAPIDLY RELEASED AFTER T-CELL ACTIVATION [J].
GRAF, D ;
MULLER, S ;
KORTHAUER, U ;
VANKOOTEN, C ;
WEISE, C ;
KROCZEK, RA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1749-1754
[9]  
GUZMAN J, 1992, J RHEUMATOL, V19, P1551
[10]   Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease [J].
Higuchi, T ;
Aiba, Y ;
Nomura, T ;
Matsuda, J ;
Mochida, K ;
Suzuki, M ;
Kikutani, H ;
Honjo, T ;
Nishioka, K ;
Tsubata, T .
JOURNAL OF IMMUNOLOGY, 2002, 168 (01) :9-12